TABLE 1

Description of participating cohorts.

Study and enrolment periodTotal subjects nMeasurement age# yearsAge years
At baselineAt end of follow-up
ABCD, The Netherlands
 2003–200427834, 5, 74.1±0.66.8±0.9
BAMSE, Sweden
 1994–199622684, 84.0±0.28.1±0.4
DARC, Denmark
 1998–19993483, 63.0±0.26.1±0.1
EDEN, France
 2003–20065924, 5, 6, 7, 84.8±0.87.8±0.6
Generation R Study, The Netherlands
 2002–200611694, 63.8±0.16.1±0.3
GINIplus, Germany
 1995–199833094, 5, 64.2±0.45.8±0.5
INMA_M, Menorca, Spain
 1997–19982494, 64.2±0.16.7±0.2
INMA_V, Valencia, Spain
 2003–20054264, 7, 94.3±0.18.0±0.6
KOALA, The Netherlands
 2002–200314714, 6, 85.0±0.57.8±0.6
LISAplus, Germany
 1997–199818814, 5, 64.3±0.45.8±0.4
MAS, Germany
 19909694, 5, 6, 74.1±0.17.0±0.5
PIAMA, The Netherlands
 1996–199729894, 5, 6, 7, 84.4±0.68.0±0.6
RHEA, Greece
 2007–20085264, 73.6±0.66.6±0.3
Bologna Birth Cohort (ROBBIC), Italy
 2004–20051893, 83.6±0.47.8±0.5
Roma Birth Cohort (ROBBIC), Italy
 2003–20044523–4, 7, 84.1±0.28.6±0.3
SWS, UK
 1998–200715093, 6, 83.1±0.18.3±1.2
All participants
 NA21 130NA4.1±0.67.1±1.2

Data are presented as mean±sd, unless otherwise stated. Only children with body mass index data for at least two follow-ups, who were non-obese at baseline and had information on at least one asthma or asthma-related phenotype were included. NA: not applicable. #: age when anthropometric measurements collected.